Art

J-GLOBAL ID：201802260986837602   Reference number：18A2086637

Screening for Fabry Disease in Japanese Patients with Young-Onset Stroke by Measuring α-Galactosidase A and Globotriaosylsphingosine

α-ガラクトシダーゼAおよびグロボトリアオシルスフィンゴシンの測定による日本の若年発症脳卒中患者におけるFabry病のスクリーニング

Author (18)： Kinoshita Naoto (Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan) ,  Hosomi Naohisa (Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan) ,  Matsushima Hayato (Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan) ,  Matsushima Hayato (Department of Neurology, Suiseikai Kajikawa Hospital, Hiroshima, Japan) ,  Nakamori Masahiro (Department of Neurology, Suiseikai Kajikawa Hospital, Hiroshima, Japan) ,  Yagita Yoshiki (Department of Stroke Medicine, Kawasaki Medical School, Kurashiki, Japan) ,  Yamawaki Takemori (Department of Neurology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan) ,  Torii Tsuyoshi (Department of Neurology, National Hospital Organization Kure Medical Center, Kure, Japan) ,  Kitamura Takeshi (Department of Neurology, Chugoku Rosai Hospital, Kure, Japan) ,  Sueda Yoshimasa (Department of Neurology, National Hospital Organization Higashihiroshima Medical Center, Higashihiroshima, Japan) ,  Shimomura Ryo (Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan) ,  Araki Mutsuko (Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan) ,  Nezu Tomohisa (Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan) ,  Aoki Shiro (Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan) ,  Ishii Satoshi (GlycoPharma Corporation, Oita, Japan) ,  Maruyama Hiroki (Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan) ,  Matsumoto Masayasu (Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan) ,  Maruyama Hirofumi (Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan)
Material： Journal of Stroke & Cerebrovascular Diseases  (J Stroke Cerebrovasc Dis)
Volume： 27  Issue： 12  Page： 3563-3569  Publication year： Dec. 2018 
JST Material Number： W1420A  ISSN： 1052-3057  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： *Fabry's disease ,...
Semi thesaurus term： genetic variation ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A2086637&from=J-GLOBAL&jstjournalNo=W1420A") }}

Author keywords (3)： Fabry disease ,  Young-onset stroke ,  Screening

JST classification (1)： Nervous system diseases  (GN03000O)

Terms in the title (8)： α-ガラクトシダーゼA ,  グロボトリアオシルスフィンゴシン ,  日本 ,  若年 ,  発症 ,  脳卒中患者 ,  Fabry病 ,  スクリーニング